Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel + cisplatin + S-1 for advanced gastric cancer
ChiCTR-ONC-11001804Phase 2Completed
- Sponsor
- The Affiliated Hospital of Guangdong Medical University
- Start
- Feb 2007
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of docetaxel, cisplatin and tegafur in gastric cancer (GC), sponsored by The Affiliated Hospital of Guangdong Medical University. Primary endpoints: Response rate, Time to progression and 2 more. Started Feb 2007; status: completed.
02
Drugs
docetaxelcisplatintegafur
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on ChiCTR-ONC-11001804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-11001804.